CD30+ LPDs include primary cutaneous anaplastic large cell lymphoma (pcALCL), lymphomatoid papulosis (LyP) and borderline CD30+ LPD. This evidence concerns the gene TNFRSF8 and disseminated peritoneal leiomyomatosis.